Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
PaperCitations, authors & open-access status
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 559 citations, 2012 year and closed oa status.
559
Citations
2012
Year
closed
OA Status